Organometallics
Article
(s), 807 (s), 733 (s), 697 (s), 616 (m), 460 (s). HR-FAB MS: calcd for
C20H17BP (M − H) 299.1165, found 299.1169; m/z (%) 299 (100)
[M − H], 209 (15) [M − BH3 − Ph], 178 (25) [M − BH3 − Ph − P],
154 (80), 136 (60), 107 (20) [C6H4P].
FAB MS: calcd for C23H23BP (M − H) 341.1635, found 341.1639; m/
z (%) 341 (100) [M − H], 328 (55) [M − BH3], 209 (20) [M − BH3
− Mes], 183 (20) [M − BH3 − Mes − CHCH], 150 (15).
5-Mesityl-5H-dibenzo[b,f ]phosphepine (6b). A 1.47 g portion
(13.10 mmol) of DABCO was added to a solution of 447 mg (1.31
mmol) of 7b in 20 mL of dichloromethane at room temperature, and
the mixture was stirred overnight. The next day the mixture was
filtered over a silica pad and then through Celite, washed with a 5%
aqueous solution of HCl, and extracted with diethyl ether. The
combined organic extracts were dried with MgSO4, and all volatiles
were evaporated under reduced pressure. This gave 398 mg (1.31
mmol, 96%) of phosphine 6b as a yellowish solid. It is recommended
to monitor the reaction by 31P NMR before isolation, since in some
cases we observed slow deborylation of the BH3 adduct. If conversion
is not completed, more DABCO should be added. Mp: 183−186 °C
(yellowish solid). 1H NMR (400 MHz, CDCl3): 2.42 (s, 6H, o-
CH3(Mes)), 2.43 (s, 3H, p-CH3(Mes)), 6.81 (t, 2H, JHH = 6.8 Hz),
6.96 (s, 2H, H-1), 7.10−7.14 (m, 4H), 7.17−7.24 (m, 4H). 31P{1H}
NMR (162 MHz, CDCl3): −30.5. 13C{1H} NMR (101 MHz): 21.4
5-Phenyl-5H-dibenzo[b,f ]phosphepine (6a). A 1.14 g portion
(10.2 mmol) of DABCO was added to a solution of 1.53 g (5.1 mmol)
of 7a in 40 mL of toluene at room temperature, and the mixture was
stirred overnight. The next day the mixture was quenched with a 5%
aqueous solution of HCl and extracted with diethyl ether. The
combined organic extracts were dried with MgSO4, and all volatiles
were removed under reduced pressure. This gave 1.42 g (4.97 mmol,
97%) of phosphine 6a as a colorless solid. It is recommended to
monitor the reaction by 31P NMR before isolation, since in some cases
we observed slow deborylation of the BH3 adduct. If conversion is not
completed, more DABCO should be added. Mp: 132−134 °C
(colorless solid). 1H NMR (500 MHz, CDCl3): 6.78 (s, 2H, H-1), 6.90
2
4
(dd, 2H, JHH = 7.7, JHP = 1.7 Hz, m-Ph), 7.13−7.20 (m, 3H, o-, p-
Ph), 7.39−7.46 (m, 6H, H-2, H-3, H-4/5), 7.83−7.88 (m, 2H, H-5/4).
31P{1H} NMR (162 MHz, CDCl3): −8.1. 13C{1H} NMR (126 MHz,
CDCl3): 127.4 (p-Ph), 127.7 (d, 2JCP = 4.8 Hz, o-Ph), 128.2 (d, JCP
=
(p-CH3(Mes)), 24.6 (d, 2JCP = 18.9 Hz, o-CH3(Mes)), 125.5 (d, 3JCP
8.4 Hz), 127.4, 128.5, 129.7 (d, JCP = 6.3 Hz), 129.8 (d, JCP = 4.7 Hz),
130.4 (d, JCP = 4.7 Hz), 134.7 (d, 3JCP = 6.3 Hz, C-1), 137.8 (d, JCP
16.5 Hz), 138.6 (d, JCP = 21.0 Hz), 140.6 (d, JCP = 1.4 Hz), 147.0 (d,
JCP = 17.2). IR: ν 3051 (w), 3012 (w), 2963 (w), 2917 (w), 2853 (w),
=
15.2, C-4/5), 129.7 (d, 4JCP = 0.7 Hz, C-3), 130.5 (d, 3JCP = 1.6 Hz, C-
3
3
2), 131.4 (d, JCP = 16.3 Hz, m-Ph), 132.6 (d, JCP = 1.3 Hz, C-1),
=
135.8 (d, 1JCP = 9.3 Hz, C-5a), 137.0 (d, JCP = 45.8 Hz, C-5/4), 137.4
(d, 1JCP = 9.5 Hz, i-Ph), 139.9 (C-1a). IR: ν
̃
3048 (m), 3009 (m), 1476
̃
(m), 1427 (m), 1264 (m), 804 (s), 775 (s), 740 (s), 694 (s), 496 (m),
460 (s). HR-ESI MS: calcd for C20H16P (M + H) 287.0984, found
297.0979; m/z (%) 287 (100) [M + H], 219 (10), 165 (80).
Reduction of 6a with Sodium. Compound 6a (143 mg, 0.5 mmol)
was dissolved in 1.5 mL of THF, and 115 mg (5.0 mmol) of sodium
was added to this solution at room temperature. Upon stirring, the
reaction mixture changed color from reddish to deep purple. After 4 h
of stirring at room temperature the solution was decanted from
unreacted sodium. The mixture was 31P NMR silent. Crystals of the
dianionic species [6a]2− were obtained by slow evaporation of pentane
into the THF solution obtained after decantation from sodium; these
were also 31P NMR silent.
1469 (m), 1423 (m), 1094 (m), 1027 (m), 800 (s), 747 (s). HR-FAB
MS: calcd for C23H22P (M + H) 329.1459, found 329.1459; m/z (%)
328 (60) [M], 281 (20), 207 (25), 147 (40), 73 (100).
Reduction of 5-Mesityl-5H-dibenzo[b,f ]phosphepine (6b) with
Sodium. Reduction was carried out similarly to the reduction of the
phosphepine 6a. The mixture was 31P NMR silent.
Tris(5-phenyl-5H-dibenzo[b,f ]phosphepine)rhodium(I) Triflate
(8a[OTf]). A solution of dibenzophosphepine 6a (0.34 mmol, 97
mg) in 5 mL of dichloromethane was added to a solution of
dicyclooctadiene rhodium(I) triflate (0.11 mmol, 51 mg) in 5 mL of
dichloromethane at room temperature. The mixture was stirred for 6
h, all volatiles were removed by vacuum evaporation, and the solid was
washed with pentane in order to get rid of COD. This gave 8a as a
yellow solid in quantitative yield. Crystals suitable for an X-ray study
can be obtained by dissolution of the complex in DCM and slow
evaporation of pentane into this solution. Mp: >270 °C (dec without
5-Mesityl-5H-dibenzo[b,f ]phosphepine−Borane (7b). A solution
of (Z)-1,2-bis(2-bromophenyl)ethene (5;27 4.70 mmol, 1.59 g) in 30
mL of diethyl ether was added dropwise to a solution of t-BuLi (18.82
mmol, 11.7 mL of a 1.7 M solution in pentane) in 30 mL of diethyl
ether at −78 °C, and the mixture was stirred for 1 h at this
temperature. Then, mesityldichlorophosphine28 (mixture of MesPCl2
and MesPClBr, approximately 4/1, 4.70 mmol, 1.08 g) in 15 mL of
diethyl ether was added, and the reaction mixture was warmed to room
temperature. The mixture was stirred at room temperature overnight.
Full conversion was observed with 31P NMR. After that a 2.0 M
solution of BH3−SMe2 in diethyl ether (4.94 mmol, 2.47 mL) was
added dropwise to the reaction mixture at room temperature. The
mixture was stirred overnight, followed by the addition of water (20
mL) and diethyl ether (40 mL), filtration through Celite, and column
chromatography purification on silica (MTBE/pentane 10/0.1, then
10/1). This gave 520 mg (1.52 mmol, 32% yield) of 7b as a colorless
solid. It is recommended to monitor the reaction by 31P NMR before
isolation, since in some cases we observed slow formation of the BH3
adduct (this, probably, depends on the quality of BH3−SMe2). If
conversion is not completed, more BH3−SMe2 solution should be
1
melting). H NMR (500 MHz, CD2Cl2, 215 K): 4.31 (s, CHCH),
4.85 (s, CHCH), 5.41−5.64 (m, Ar), 6.06 (s, CHCH), 6.58−7.91
(m, Ar). 31P{1H} NMR (202 MHz, CD2Cl2, 215 K): 19.7 (ddd, 1JPRh
=
=
=
119.0, 2JPP = 38.1, 2JPP = 21.8 Hz, 1P), 31.4 (ddd, 2JPP = 395.0, 1JPRh
2
2
1
2
95.2, JPP = 21.8 Hz, 1P), 39.2 (ddd, JPP = 395.0, JPRh = 95.2, JPP
38.1 Hz, 1P). 19F{1H} NMR (235 MHz, CD2Cl2, 298 K): −153.7. IR:
̃
ν 2966 (w), 2920 (w), 2850 (w), 1455 (w), 1356 (w), 1278 (m), 1260
(s), 1083 (m), 1027 (s), 793 (s). HR-FAB MS: calcd for C60H45P3Rh
(M − OTf) 961.1789, found 961.1786; m/z (%) 961 (12) [M −
OTf], 675 (100) [M − OTf − 6a], 497 (10), 389 (25) [M − OTf −
26a], 154 (48), 136 (33).
Bis(5-mesityl-5H-dibenzo[b,f ]phosphepine)rhodium(I) Triflate
(8b[OTf]). A solution of dibenzophosphepine 6b (0.30 mmol, 100
mg) in 2 mL of dichloromethane was added at room temperature to a
solution of dicyclooctadiene rhodium(I) triflate (0.15 mmol, 71 mg) in
2 mL of dichloromethane. The mixture was stirred at room
temperature for 2 h, and then all volatiles were removed by vacuum
evaporation and the solid was washed with diethyl ether. This gave 130
mg (0.14 mmol, 93%) of a mixture of cis and trans isomers of complex
8b (the ratio according to 31P NMR is 1/0.1). The major isomer can
be obtained by slow crystallization from a dichloromethane solution of
the mixture, covered by pentane. This gives 75 mg (0.083 mmol, 55%)
of the cis isomer as deep red needles. 31P{1H} NMR of the crude
mixture of cis and trans isomers (signal ratio is 1/0.1; 101 MHz,
1
added. Mp: 181−183 °C (colorless crystals). H NMR (400 MHz,
CDCl3): 1.43 (q, 3H, 1JHB = 79.5 Hz, BH34), 1.55 (s, 6H, o-CH3(Mes)),
2.19 (s, 3H, p-CH3(Mes)), 6.63 (d, 2H, JHP = 2.8 Hz, m-Mes), 6.85
(s, 2H, H-1), 7.38 (d, 2H, 4JHP = 6.9 Hz, H-2), 7.48−7.57 (m, 4H, H-3,
H-4), 8.36−8.42 (m, 2H, H-5). 31P{1H} NMR (162 MHz, CDCl3):
1
10.4 (q, JPB = 74.1 Hz). 11B NMR (128 MHz, CDCl3): −39.8 (m).
13C{1H} NMR (101 MHz, CDCl3): 20.9 (s, p-CH3(Mes)), 22.8 (d,
1
3JCP = 5.5 Hz, o-CH3(Mes)), 121.5 (d, JCP = 57.2 Hz, i-Mes), 128.7
1
1
(d, 3JCP = 6.6 Hz, C-2), 129.2 (d, 3JCP = 13.0 Hz, C-4), 130.5 (d, 1JCP
=
CD2Cl2): 34.6 (d, JPRh = 149.0 Hz), 43.1 (d, JPRh = 127.3 Hz). Mp
243−246 °C (red solid). NMR spectra of the purified cis-8b[OTf]: 1H
NMR (400 MHz, CD2Cl2) 1.97 (s, 6H, o-CH3(Mes)), 2.32 (s, 3H, p-
CH3(Mes)), 6.20 (s, 2H, H-1), 6.70 (s, 2H, m-Mes), 7.09−7.14 (m,
2H, H-3/4/5), 7.21−7.26 (m, 4H, H-3/4/5), 7.51 (d, 2H, J = 4.6 Hz,
H-2); 31P{1H} NMR (162 MHz, CD2Cl2) 34.6 (d, 1JPRh = 149.0 Hz);
56.1 Hz, C-5a), 130.68 (C-3), 130.73 (d, 3JCP = 6.5 Hz, m-Mes), 131.7
3
2
(d, JCP = 1.7 Hz, C-1), 133.1 (d, JCP = 18.1 Hz, C-5), 138.4 (C-1a),
139.7 (d, 4JCP = 2.6 Hz, p-Mes), 142.0 (d, 2JCP = 8.5 Hz, o-Mes). IR: ν
̃
3058 (w), 3016 (w), 2970 (w), 2927 (w), 2382 (s), 2343 (m), 1451
(m), 1136 (w), 1058 (s), 804 (s), 775 (m), 743 (m), 460 (m). HR-
I
dx.doi.org/10.1021/om301012z | Organometallics XXXX, XXX, XXX−XXX